Also, LCF granule treatment led to much higher levels of Sirt1 and Nrf2, two key modulators that inhibit the pathological progression of SLE and LN, in the kidney tissues of MRL/lpr mice (Figure 3). The gene discussed is SIRT1; the disease is systemic lupus erythematosus.